Press release Read more about KCC Annual Report and ESG Performance Report 2022 - Concluding a record-breaking year with solid progress across KCC’s business
Press release Read more about Press Release: Dupixent® (dupilumab) application for treatment of chronic spontaneous urticaria (CSU) in adults and adolescents accepted for FDA review
Press release Read more about Mercialys: Number of Outstanding Shares and Voting Rights as of February 28, 2023
Press release Read more about Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update